These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 17729248)

  • 1. Re: Loss of antibody titers and effectiveness of revaccination in post-chemotherapy pediatric sarcoma patients.
    Arya SC; Agarwal N
    Pediatr Blood Cancer; 2008 Apr; 50(4):933; author reply 933-4. PubMed ID: 17729248
    [No Abstract]   [Full Text] [Related]  

  • 2. Loss of antibody titers and effectiveness of revaccination in post-chemotherapy pediatric sarcoma patients.
    Yu J; Chou AJ; Lennox A; Kleiman P; Wexler LH; Meyers PA; Gorlick R
    Pediatr Blood Cancer; 2007 Oct; 49(5):656-60. PubMed ID: 17554790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Centenary of the Health Council of the Netherlands. IV. Infectious diseases].
    Cohen H; Hofman B
    Ned Tijdschr Geneeskd; 2002 Dec; 146(50):2454; author reply 2454-5. PubMed ID: 12518530
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibodies to SV40 in sera from humans and macaques.
    Minor P; Pipkin PA
    Dev Biol (Basel); 2006; 123():99-107; discussion 119-32. PubMed ID: 16566439
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of a two-dose administration of live oral poliovirus vaccine for wild and virulent vaccine-derived poliovirus type 1, 2, 3 strains in Japan.
    Iwai M; Takizawa T; Nakayama T; Matsuura K; Yoshida H; Hasegawa S; Obara M; Horimoto E; Kurata T; Horie H
    Scand J Infect Dis; 2008; 40(3):247-53. PubMed ID: 17907043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pathogenesis of poliomyelitis: what we don't know.
    Nathanson N
    Adv Virus Res; 2008; 71():1-50. PubMed ID: 18585526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective inactivated or live poliovirus vaccine: effectiveness in the 21st Century.
    Arya SC; Agarwal N
    Expert Rev Vaccines; 2009 Feb; 8(2):127-30. PubMed ID: 19196189
    [No Abstract]   [Full Text] [Related]  

  • 8. [Genetic evolution of poliovirus: success and difficulties in the eradication of paralytic poliomyelitis].
    Blondel B; Autret A; Brisac C; Pelletier I; Martin-Latil S; Jegouic S; Bessaud M; Joffret ML; Balanant J; Colbère-Garapin F; Delpeyroux F
    Med Trop (Mars); 2008 Apr; 68(2):189-202. PubMed ID: 18630055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines given separately or combined for booster dosing at 4-6 years of age.
    Black S; Friedland LR; Ensor K; Weston WM; Howe B; Klein NP
    Pediatr Infect Dis J; 2008 Apr; 27(4):341-6. PubMed ID: 18316985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The (too) slow agony of poliovirus].
    Vos A
    Rev Med Suisse; 2005 Nov; 1(40):2628. PubMed ID: 16353849
    [No Abstract]   [Full Text] [Related]  

  • 11. Polio eradication campaign copes with unusual outbreak.
    Willyard C
    Nat Med; 2007 Dec; 13(12):1394. PubMed ID: 18064018
    [No Abstract]   [Full Text] [Related]  

  • 12. Seroprevalence of anti-polio antibodies in a population 7 months to 39 years of age in Uruguay: Implications for future polio vaccination strategies.
    Pírez MC; Olivera I; Diabarboure H; Montano A; Barañano R; Badía F; Bonnet MC
    Vaccine; 2009 May; 27(20):2689-94. PubMed ID: 19428880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Problems with the oral polio vaccine.
    Bhasin VK
    Nat Med; 2008 Jan; 14(1):9. PubMed ID: 18180708
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical course of classic Kaposi's sarcoma in HIV-negative patients treated with the HIV protease inhibitor indinavir.
    Monini P; Sgadari C; Grosso MG; Bellino S; Di Biagio A; Toschi E; Bacigalupo I; Sabbatucci M; Cencioni G; Salvi E; Leone P; Ensoli B
    AIDS; 2009 Feb; 23(4):534-8. PubMed ID: 19169139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine-derived poliovirus (VDPV): Impact on poliomyelitis eradication.
    Minor P
    Vaccine; 2009 May; 27(20):2649-52. PubMed ID: 19428874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal immunity following a combined enhanced inactivated polio vaccine/oral polio vaccine programme in Israel.
    Swartz TA; Green MS; Handscher R; Sofer D; Cohen-Dar M; Shohat T; Habib S; Barak E; Dror Z; Somekh E; Peled-Leviathan T; Yulzari R; Libling A; Mendelson E; Shulman LM
    Vaccine; 2008 Feb; 26(8):1083-90. PubMed ID: 18241962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral immune response after post-chemotherapy booster diphtheria-tetanus-pertussis vaccine in pediatric oncology patients.
    Cheng FW; Leung TF; Chan PK; Lee V; Shing MK; Chik KW; Yuen PM; Li CK
    Pediatr Blood Cancer; 2009 Feb; 52(2):248-53. PubMed ID: 18937325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polio eradication remains a challenge.
    Falleiros-Carvalho LH
    Vaccine; 2009 May; 27(21):2731-2. PubMed ID: 19428885
    [No Abstract]   [Full Text] [Related]  

  • 19. The maintaining of the active laboratory-based surveillance of the acute flaccid paralysis (AFP) cases in Romania in the framework of the strategic plan of the global polio eradication initiative.
    Băicuş A; Persu A; Combiescu M; Aubert-Combiescu A
    Roum Arch Microbiol Immunol; 2007; 66(1-2):44-50. PubMed ID: 18928063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of the frequency of antibody and titers against human herpesvirus 8 latent and lytic antigens in "at-risk" individuals and among patients with Kaposi's sarcoma.
    Magri MC; Carbone PH; de los Santos-Fortuna E; Caterino-de-Araujo A
    J Med Virol; 2009 Jul; 81(7):1292-7. PubMed ID: 19475629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.